Robot-assisted walking treatment for hereditary spastic paraplegia
Official title: Efficacy of Robot-assisted Walking Treatment on Gait Biomechanics, Functional Outcomes, and Quality of Life in Subjects With Hereditary Spastic Paraplegia (HSP)
Run by IRCCS Eugenio Medea · NCT06728787 · Data updated 2026-11-12
This study is testing whether using a robot to help with walking, along with regular physical therapy, can improve movement and quality of life for people with hereditary spastic paraplegia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 4 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | IRCCS Eugenio Medea Academic / other |
| Locations | 1 site (Bosisio Parini, Italy/lecco) |
| Status | Recruiting |
| Started | January 1, 2012 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 4, 2025 |
| Trial ID | NCT06728787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 4 to 70 with a genetic or clinical diagnosis of hereditary spastic paraplegia who can walk independently.
✕Probably not a fit
Patients with severe lower limb muscle retractions, recent lower limb surgeries, or acute neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the effectiveness of a combined rehabilitation approach using the Lokomat robotic gait training system alongside traditional physical therapy for patients with hereditary spastic paraplegia (HSP). Participants will undergo a total of 30 sessions over three weeks, with assessments conducted before, after treatment, and at a three-month follow-up. The study aims to measure improvements in gait, functional abilities, and quality of life through various clinical-functional assessments. This approach seeks to enhance the rehabilitation experience and outcomes for individuals affected by this rare neurological disorder.
Why it matters
Potential benefit: If successful, this treatment could significantly improve mobility and quality of life for patients with hereditary spastic paraplegia.
How similar studies have gone: Previous studies using robotic gait training in neurological disorders have shown promising results, suggesting potential efficacy for this approach in hereditary spastic paraplegia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * genetic or clinical diagnosis of HSP. * age greater than 4 years and less than 70 * femur length \> 23 cm * ability to walk independently indoors, with or without walking aids. Exclusion Criteria: * botulinum toxin injection or lower limb surgery in the previous 6 months * severe lower limb muscle retractions * severe osteoporosis * unhealed skin lesions in lower limbs * cardiovascular instability * acute or progressive neurological disorders * behavioral problemS
Where it's running
-
Irccs Eugenio Medea
Bosisio Parini, Italy/lecco, Italy Recruiting
Study contacts
- Study coordinator: Eleonora Diella
- Email: eleonora.diella@lanostrafamiglia.it
- Phone: 3286859456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rare Disease Registry for Movement Disorders in Southern Anhui
This project is creating a registry to collect information from adults with motor neuron diseases, spinocerebellar ataxias, hereditary muscular dystrophy, or hereditary spastic paraplegia in Southern Anhui.
-
TreatHSP/SPAX: An adaptive natural history platform for SPAX diseases
This study tests a shared, long-term framework to track how SPAX diseases progress and to develop useful patient-centered outcome measures and biomarkers.
-
Noninvasive spinal stimulation to improve walking in hereditary spastic paraplegia
This trial will test whether noninvasive transcutaneous spinal cord stimulation can improve walking and reduce muscle stiffness in adults with hereditary spastic paraplegia.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Evaluating surgical treatment for foot deformities in hereditary spastic paraplegia
This study is testing how well surgery can help people with hereditary spastic paraplegia and foot deformities feel and function better over two years.
-
Exploring intrathecal baclofen treatment for hereditary spastic paraplegia
This study is testing if a special pump that delivers baclofen directly into the spine can help people with hereditary spastic paraplegia improve their movement and quality of life better than taking the medication by mouth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.